October FDA news in review

FDA News in Review

Welcome to the October installment of "FDA News in Review," where each month we look at the agency's latest decision, approvals, warnings and recalls. Over the last few days one of the hottest topics in pharma has been the issue of preemption, which is being argued before the Supreme Court in the case of Wyeth v. Levine. Another important story this month was the FDA's continuing difficulty meeting drug approval deadlines. To get the full scoop on October, check out this report.

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.